As the Schmidtknects told WMTV previously, their son had had asthma since he was an infant, but the advent of Advair's preventative Diskus inhaler had been "life-changing" for managing his symptoms.

The parents of a 22-year-old Wisconsin man who died after an asthma attack have filed a lawsuit against Walgreens and UnitedHealth Group’s pharmacy benefit manager after they said the price for ...

The complaint alleges that at the start of 2024, OptumRx discontinued coverage of the inhaler Cole Schmidtknecht used, Advair Diskus, and its generic versions, in a decision that was not medically ...

The main patent on Advair (fluticasone+salmeterol) expired as long ago as 2010, while the patent on GSK’s Diskus inhaler expired in 2016. But Mylan became the first of a group of potential ...

Without his daily inhaler to help control the symptoms of ... when a medication is not covered on formulary, including Advair Diskus formulary alternatives with member copays as low as $5.” ...

The purpose of this study was therefore to demonstrate that doubling the dose of Seretide™ administered via a Diskus™ inhaler in subjects with varying degrees of asthma is safe and well ...

He managed it with daily doses of the medication Advair Diskus and its generic equivalents, which he ingested through an inhaler. He stopped at a Walgreens pharmacy in Appleton on Jan. 10 ...

His plan through OptumRx, a subsidiary of United Health Group, covered the corticosteroid inhaler Advair Diskus. Through the plan, Schmidtknecht paid roughly $35 to up to $66.86 during the ...

During the run-in, all subjects were required to stop their inhaled corticosteroid and long-acting β 2-agonist if appropriate and take Seretide™ one inhalation twice daily from a Diskus ...